NantHealth (NASDAQ: NH)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.110 | -0.0200 | ||||
REV | 16.420M | 16.373M | -47.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of NantHealth (NASDAQ: NH) through any online brokerage.
Other companies in NantHealth’s space includes: Pear Therapeutics (NASDAQ:PEAR), Better Therapeutics (NASDAQ:BTTX), CareCloud (NASDAQ:MTBC), UpHealth (NYSE:UPH) and Renalytix (NASDAQ:RNLX).
The latest price target for NantHealth (NASDAQ: NH) was reported by Canaccord Genuity on Friday, November 17, 2017. The analyst firm set a price target for 5.00 expecting NH to rise to within 12 months (a possible 1061.71% upside). 0 analyst firms have reported ratings in the last year.
The stock price for NantHealth (NASDAQ: NH) is $0.4304 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for NantHealth.
NantHealth’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for NantHealth.
NantHealth is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.